Anti-tumoral effect of the mitochondrial target domain of noxa delivered by an engineered Salmonella typhimurium

PLoS ONE

Volumn 9, Issue 1, 2014, Pages

  Jeong, Jae Ho ^a   Kim, Kwangsoo ^a   Lim, Daejin ^a   Jeong, Kwangjoon ^a   Hong, Yeongjin ^a   Nguyen, Vu H ^a   Kim, Tae Hyoung ^b   Ryu, Sangryeol ^c   Lim, Jeong A ^c   Kim, Jae Il ^d   Kim, Geun Joong ^e   Kim, Sun Chang ^f   Min, Jung Joon ^a   Choy, Hyon E ^a  

^a Chonnam National University Medical School   (South Korea)

^b Chosun University College of Medicine   (South Korea)

^c Seoul National University   (South Korea)

^d Gwangju Institute of Science and Technology (GIST)   (South Korea)

^e Chonnam National University   (South Korea)

^f Korea Advanced Institute of Science and Technology (KAIST)   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ARABINOSE; CELL PENETRATING PEPTIDE; L ARABINOSE; MITOCHONDRIAL TARGETING DOMAIN OF NOXA; PROTEIN NOXA; UNCLASSIFIED DRUG; VOLTAGE GATED POTASSIUM CHANNEL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BACTERIAL CANCER THERAPY; BACTERIAL STRAIN; BACTERIOLYSIS; CANCER CELL; CANCER THERAPY; COLON CARCINOMA; CONTROLLED STUDY; GENETIC CODE; IN VIVO STUDY; MALE; MITOCHONDRION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN DOMAIN; SALMONELLA TYPHIMURIUM;

AMINO ACID SEQUENCE; ANIMALS; ANTINEOPLASTIC AGENTS; ARABINOSE; BACTERIOLYSIS; CELL DEATH; CELL LINE, TUMOR; CELL-PENETRATING PEPTIDES; GENE TRANSFER TECHNIQUES; GENETIC ENGINEERING; HUMANS; MICE; MITOCHONDRIA; MOLECULAR SEQUENCE DATA; PHENOTYPE; PLASMIDS; PROTEIN STRUCTURE, TERTIARY; PROTO-ONCOGENE PROTEINS C-BCL-2; SALMONELLA TYPHIMURIUM; TISSUE DISTRIBUTION;

EID: 84897440929     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0080050     Document Type: Article

References (59)

1. Levesque AA, Eastman A (2007) p53-based cancer therapies: Is defective p53 the Achilles heel of the tumor? Carcinogenesis 28: 13-20. (Pubitemid 44942622)
2. Martins CP, Brown-Swigart L, Evan GI (2006) Modeling the therapeutic efficacy of p53 restoration in tumors. Cell 127: 1323-1334. (Pubitemid 44960417)
3. Hengartner MO (2000) The biochemistry of apoptosis. Nature 407: 770-776.
4. Cory S, Huang DC, Adams JM (2003) The Bcl-2 family: roles in cell survival and oncogenesis. Oncogene 22: 8590-8607. (Pubitemid 38028528)
5. Adams JM, Cory S (2007) The Bcl-2 apoptotic switch in cancer development and therapy. Oncogene 26: 1324-1337. (Pubitemid 46328466)
6. Petros AM, Olejniczak ET, Fesik SW (2004) Structural biology of the Bcl-2 family of proteins. Biochim Biophys Acta 1644: 83-94. (Pubitemid 38281265)
7. Ehrhardt H, Hofig I, Wachter F, Obexer P, Fulda S, et al. (2012) NOXA as critical mediator for drug combinations in polychemotherapy. Cell Death Dis 3: e327.
8. Zhang L, Lopez H, George NM, Liu X, Pang X, et al. (2011) Selective involvement of BH3-only proteins and differential targets of Noxa in diverse apoptotic pathways. Cell Death Differ 18: 864-873.
9. Suzuki S, Nakasato M, Shibue T, Koshima I, Taniguchi T (2009) Therapeutic potential of proapoptotic molecule Noxa in the selective elimination of tumor cells. Cancer Sci 100: 759-769.
10. Seo YW, Woo HN, Piya S, Moon AR, Oh JW, et al. (2009) The cell death-inducing activity of the peptide containing Noxa mitochondrial-targeting domain is associated with calcium release. Cancer Res 69: 8356-8365.
11. Seo YW, Shin JN, Ko KH, Cha JH, Park JY, et al. (2003) The molecular mechanism of Noxa-induced mitochondrial dysfunction in p53-mediated cell death. J Biol Chem 278: 48292-48299. (Pubitemid 37523284)
12. Nauts HC, Fowler GA, Bogatko FH (1953) A review of the influence of bacterial infection and of bacterial products (Coley's toxins) on malignant tumors in man; a critical analysis of 30 inoperable cases treated by Coley's mixed toxins, in which diagnosis was confirmed by microscopic examination selected for special study. Acta Med Scand Suppl 276: 1-103.
13. Min JJ, Nguyen VH, Kim HJ, Hong Y, Choy HE (2008) Quantitative bioluminescence imaging of tumor-targeting bacteria in living animals. Nat Protoc 3: 629-636. (Pubitemid 351516759)
14. Forbes NS (2010) Engineering the perfect (bacterial) cancer therapy. Nat Rev Cancer 10: 785-794.
15. Yu YA, Shabahang S, Timiryasova TM, Zhang Q, Beltz R, et al. (2004) Visualization of tumors and metastases in live animals with bacteria and vaccinia virus encoding light-emitting proteins. Nat Biotechnol 22: 313-320. (Pubitemid 38295764)
16. Pawelek JM, Low KB, Bermudes D (1997) Tumor-targeted Salmonella as a novel anticancer vector. Cancer Res 57: 4537-4544. (Pubitemid 27441058)
17. Toso JF, Gill VJ, Hwu P, Marincola FM, Restifo NP, et al. (2002) Phase I study of the intravenous administration of attenuated Salmonella typhimurium to patients with metastatic melanoma. J Clin Oncol 20: 142-152. (Pubitemid 34032605)
18. Thamm DH, Kurzman ID, King I, Li Z, Sznol M, et al. (2005) Systemic administration of an attenuated, tumor-targeting Salmonella typhimurium to dogs with spontaneous neoplasia: phase I evaluation. Clin Cancer Res 11: 4827-4834. (Pubitemid 41557202)
19. Nguyen VH, Kim HS, Ha JM, Hong Y, Choy HE, et al. (2010) Genetically engineered Salmonella typhimurium as an imageable therapeutic probe for cancer. Cancer Res 70: 18-23.
20. Blight MA, Holland IB (1994) Heterologous protein secretion and the versatile Escherichia coli haemolysin translocator. Trends Biotechnol 12: 450-455. (Pubitemid 24327510)
21. Shokri A, Sanden AM, Larsson G (2003) Cell and process design for targeting of recombinant protein into the culture medium of Escherichia coli. Appl Microbiol Biotechnol 60: 654-664. (Pubitemid 36286671)
22. Jain V, Mekalanos JJ (2000) Use of lambda phage S and R gene products in an inducible lysis system for Vibrio cholerae- and Salmonella enterica serovar typhimurium-based DNA vaccine delivery systems. Infect Immun 68: 986-989. (Pubitemid 30056568)
23. Maratea D, Young K, Young R (1985) Deletion and fusion analysis of the phage phi X174 lysis gene E. Gene 40: 39-46. (Pubitemid 16132024)
24. Miksch G, Fiedler E, Dobrowolski P, Friehs K (1997) The kil gene of the ColE1 plasmid of Escherichia coli controlled by a growth-phase-dependent promoter mediates the secretion of a heterologous periplasmic protein during the stationary phase. Arch Microbiol 167: 143-150. (Pubitemid 27141764)
25. Garrett J, Bruno C, Young R (1990) Lysis protein S of phage lambda functions in Saccharomyces cerevisiae. J Bacteriol 172: 7275-7277.
26. Garrett J, Fusselman R, Hise J, Chiou L, Smith-Grillo D, et al. (1981) Cell lysis by induction of cloned lambda lysis genes. Mol Gen Genet 182: 326-331. (Pubitemid 11007705)
27. Young R, Blasi U (1995) Holins: form and function in bacteriophage lysis. FEMS Microbiol Rev 17: 191-205.
28. Schwarze SR, Ho A, Vocero-Akbani A, Dowdy SF (1999) In vivo protein transduction: delivery of a biologically active protein into the mouse. Science 285: 1569-1572. (Pubitemid 29420581)
29. Lindgren M, Hallbrink M, Prochiantz A, Langel U (2000) Cell-penetrating peptides. Trends Pharmacol Sci 21: 99-103. (Pubitemid 30114324)
30. Gariepy J, Kawamura K (2001) Vectorial delivery of macromolecules into cells using peptide-based vehicles. Trends Biotechnol 19: 21-28. (Pubitemid 32056177)
31. Wadia JS, Dowdy SF (2002) Protein transduction technology. Curr Opin Biotechnol 13: 52-56. (Pubitemid 34146548)
32. Nagahara H, Vocero-Akbani AM, Snyder EL, Ho A, Latham DG, et al. (1998) Transduction of full-length TAT fusion proteins into mammalian cells: TATp27Kip1 induces cell migration. Nat Med 4: 1449-1452. (Pubitemid 28553472)
33. Dom G, Shaw-Jackson C, Matis C, Bouffioux O, Picard JJ, et al. (2003) Cellular uptake of Antennapedia Penetratin peptides is a two-step process in which phase transfer precedes a tryptophan-dependent translocation. Nucleic Acids Res 31: 556-561. (Pubitemid 36175944)
34. Borjesson SI, Elinder F (2008) Structure, function, and modification of the voltage sensor in voltage-gated ion channels. Cell Biochem Biophys 52: 149-174.
35. Krepkiy D, Mihailescu M, Freites JA, Schow EV, Worcester DL, et al. (2009) Structure and hydration of membranes embedded with voltage-sensing domains. Nature 462: 473-479.
36. Song M, Kim HJ, Kim EY, Shin M, Lee HC, et al. (2004) ppGpp-dependent stationary phase induction of genes on Salmonella pathogenicity island 1. J Biol Chem 279: 34183-34190. (Pubitemid 39318041)
37. Kim K, Jeong JH, Lim D, Hong Y, Yun M, et al. (2013) A Novel Balanced-Lethal Host-Vector System Based on glmS. PLoS One 8: e60511.
38. Datsenko KA, Wanner BL (2000) One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc Natl Acad Sci U S A 97: 6640-6645. (Pubitemid 30412767)
39. Davis RW, Botstein D, Roth JR (1980) Advanced bacterial genetics: A manual for genetic engineering. Cold Spring Harbor Laboratory, Cold Spring Harbor, New York.
40. Guzman LM, Belin D, Carson MJ, Beckwith J (1995) Tight regulation, modulation, and high-level expression by vectors containing the arabinose PBAD promoter. J Bacteriol 177: 4121-4130.
41. Simons RW, Houman F, Kleckner N (1987) Improved single and multicopy lac-based cloning vectors for protein and operon fusions. Gene 53: 85-96. (Pubitemid 17090099)
42. Miller JH (1972) Experiments in molecular genetics. Cold Spring Harbor, N.Y.: Cold Spring Harbor Laboratory. xvi, 466 p. p.
43. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254.
44. Thomas SM, Grandis JR (2004) Pharmacokinetic and pharmacodynamic properties of EGFR inhibitors under clinical investigation. Cancer Treat Rev 30: 255-268. (Pubitemid 38477271)
45. Park SY, Lee JY, Chang WS, Choy HE, Kim GJ (2011) A coupling process for improving purity of bacterial minicells by holin/lysin. J Microbiol Methods 86: 108-110.
46. Sarvas M (1971) Mutant of Escherichia coli K-12 defective in D-glucosamine biosynthesis. J Bacteriol 105: 467-471.
47. Wu HC, Wu TC (1971) Isolation and characterization of a glucosamine-requiring mutant of Escherichia coli K-12 defective in glucosamine-6-phosphate synthetase. J Bacteriol 105: 455-466.
48. Mengin-Lecreulx D, van Heijenoort J (1993) Identification of the glmU gene encoding N-acetylglucosamine-1-phosphate uridyltransferase in Escherichia coli. J Bacteriol 175: 6150-6157. (Pubitemid 23292428)
49. Jiang SN, Park SH, Lee HJ, Zheng JH, Kim HS, et al. (2013) Engineering of Bacteria for the Visualization of Targeted Delivery of a Cytolytic Anti-Cancer Agent. Mol Ther.
50. Hill PJ, Stritzker J, Scadeng M, Geissinger U, Haddad D, et al. (2011) Magnetic resonance imaging of tumors colonized with bacterial ferritin-expressing Escherichia coli. PLoS One 6: e25409.
51. Westphal K, Leschner S, Jablonska J, Loessner H, Weiss S (2008) Containment of tumor-colonizing bacteria by host neutrophils. Cancer Res 68: 2952-2960. (Pubitemid 351556296)
52. Deshayes S, Heitz A, Morris MC, Charnet P, Divita G, et al. (2004) Insight into the mechanism of internalization of the cell-penetrating carrier peptide Pep-1 through conformational analysis. Biochemistry 43: 1449-1457. (Pubitemid 38200550)
53. Clairmont C, Lee KC, Pike J, Ittensohn M, Low KB, et al. (2000) Biodistribution and genetic stability of the novel antitumor agent VNP20009, a genetically modified strain of Salmonella typhimurium. J Infect Dis 181: 1996-2002. (Pubitemid 30416163)
54. Le UN, Kim HS, Kwon JS, Kim MY, Nguyen VH, et al. (2011) Engineering and visualization of bacteria for targeting infarcted myocardium. Mol Ther 19: 951-959.
55. Aderem A, Underhill DM (1999) Mechanisms of phagocytosis in macrophages. Annu Rev Immunol 17: 593-623. (Pubitemid 29241135)
56. Stritzker J, Weibel S, Hill PJ, Oelschlaeger TA, Goebel W, et al. (2007) Tumor-specific colonization, tissue distribution, and gene induction by probiotic Escherichia coli Nissle 1917 in live mice. Int J Med Microbiol 297: 151-162. (Pubitemid 46678925)
57. Jain RK, Forbes NS (2001) Can engineered bacteria help control cancer? Proc Natl Acad Sci U S A 98: 14748-14750. (Pubitemid 34013912)
58. Streilein JW (1995) Unraveling immune privilege. Science 270: 1158-1159.
59. Jarvik T, Smillie C, Groisman EA, Ochman H (2010) Short-term signatures of evolutionary change in the Salmonella enterica serovar typhimurium 14028 genome. J Bacteriol 192: 560-567.